Bank Of America Corp Argenx Se Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Argenx Se stock. As of the latest transaction made, Bank Of America Corp holds 290,201 shares of ARGX stock, worth $171 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
290,201
Previous 273,556
6.08%
Holding current value
$171 Million
Previous $108 Million
15.87%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ARGX
# of Institutions
383Shares Held
31.6MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.3 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.07 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.45 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.13 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$890 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.6B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...